Heart Failure & Death Increases With Use of Avandia: New Study
Canadian researchers, on August 18, 2009, stated that the type 2 diabetes drug Avandia (generic: rosiglitazone) increases the risk of heart failure and death more than Actos (generic: (pioglitazone), another drug in the same class. As far back as 2008, Avandia has been the subject of controversy, when it was ...
